Clinical details and the ELISA results of the serum samples of the GBS patients, with (CMV+GBS) and without (CMV-GBS) a recent CMV infection

Patient groupAgeSexPreceding eventsDays from onsetDisability grade at sample dateWorst sensory gradeIgM anti-GM1 abIgM anti-GM2 abIgM anti-GD1a abIgM anti-GD1b ab
CMV+GBS:
122MURTI751−(−)+(+)−(−)−(−)
 231FURTI953±(−)+(+)w(−)−(−)
 315FURTI752
 421FNone1821−(−)−(+)−(−)−(−)
 526MNone1442−(−)+(+)w(+)−(−)
 629MFlu vac843+(+)+(+)−(−)+(w)
 726MURTI1441±(−)−(−)w(−)−(−)
 871MURTI441
 917FURTI1241±(+)+(+)−(−)−(−)
 1048FOperation851±(+)−(−)−(−)−(−)
 1158FURTI1253−(−)−(−)−(−)−(−)
 1213FNone1441+(+)+(+)+(+)+(+)
 1319FURTI921−(−)−(−)+(+)−(−)
 1421FNone851
n=1430 (17)5M, 9F10(4)4(1)2(1)4632
CMV-GBS:
n=1233 (22)7M, 5F11(6)4(1)2(1)0000
  • Values ( ) in the last two rows are mean (SD).

  • +=positive (a value greater than the NC mean+3 SD); w=weak positive, ±=border line, (+) or (−)=positive or negative by TLC; URTI=upper respiratory tract infection; ab=antibody; vac=vaccine.

  • Patient 2, but none of the others, had serological evidence of a recentCampylobacter jejuni infection.

  • An ELISA negative serum (patient 4) gave a positive band in TLC. This might be due to a difference in the epitope specificity of the antibody, but as this result was not confirmed by both methods, it was not regarded as positive.

  • Patient 8, but none of the others, had positive IgG antibodies to GM1 and GD1b.